AHR Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
674.3M
+3.6%
650.8M
+7.7%
604.1M
+5.4%
572.9M
+5.6%
542.5M
Cost of Revenue
524.8M
+2.5%
512.2M
+6.6%
480.3M
+5.7%
454.5M
+6.6%
426.3M
Gross Profit
149.4M
+7.8%
138.6M
+12.0%
123.8M
+4.5%
118.4M
+1.9%
116.2M
Operating Expenses
107.0M
+6.8%
100.2M
+14.7%
87.4M
+15.0%
75.9M
+8.8%
69.8M
R&D
0
0
0
0
0
SG&A
19.9M
+13.0%
17.6M
+6.5%
16.5M
+17.2%
14.1M
-5.6%
14.9M
Operating Income
42.4M
+10.4%
38.4M
+5.5%
36.4M
-14.2%
42.5M
-8.5%
46.4M
EBITDA
108.4M
-7.2%
116.8M
+12.4%
103.9M
+2.7%
101.2M
+29.0%
78.5M
Net Income
31.0M
+29.0%
24.0M
+119.5%
10.9M
-80.7%
56.6M
+462.0%
10.1M
EPS (Basic)
$0.16
+23.1%
$0.13
+116.7%
$0.06
-81.8%
$0.33
+450.0%
$0.06
EPS (Diluted)
$0.16
+23.1%
$0.13
+116.7%
$0.06
-81.8%
$0.33
+450.0%
$0.06
Shares (Diluted)
193.3M
+2.9%
188.0M
+4.7%
179.5M
+5.7%
169.8M
+5.4%
161.1M
American Healthcare REIT (AHR) โ€” Financials